Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.

Clinical trial NCT00366249 · COMPLETED

Trial details

NCT number: NCT00366249
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bacterial Infections Diabetic Foot Osteomyelitis

Start date: 2007-01-01
Primary completion: 2009-03-01
Enrollment: 1061

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.